A Randomized, Phase 2 Study of 24-hour Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma

Article full text

The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.